Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
Early administration of high-titre COVID-19 convalescent plasma prevents hospitalisation and death in immunocompromised ...
Georgetown University psychologist Andrea Bonior told Fox News Digital she has seen an uptick in patients, many of whom are ...
The difficulty of securing insurance coverage can impede the therapy process. Armed with advice and templates, a nonprofit is helping patients and providers get what they're due.
6d
Live Science on MSN'In that moment, that was everything to me': Patient describes joy of regaining vision in 1 eye after new stem cell therapyA first-of-its-kind stem cell transplant has changed the life of a man who was left blind in one eye following a firework ...
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...
Anxiety is common among children visiting the ED, particularly when care involves painful or frightening processes such as ...
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...
9h
News-Medical.Net on MSNGroundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth HoustonA stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.
An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.
Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results